This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wosikowski, K. Articles by Löser, R. Search for Related Content PubMed PubMed Citation Articles by Wosikowski, K. Articles by Löser, R.

WK175, a Novel Antitumor Agent, Decreases the Intracellular Nicotinamide Adenine Dinucleotide Concentration and Induces the Apoptotic Cascade in Human Leukemia Cells

Pharmacology Department, Klinge Pharma, 81673 Munich, Germany

We recently developed a class of novel antitumor agents that elicit a potent growth-inhibitory response in many tumor cells cultured in vitro. WK175, a member of this class, was chosen as a model compound that showed strong in vitro efficacy. WK175 interferes with the intracellular steady-state level of NAD⁺, resulting in a decreased cellular NAD⁺ concentration. We found that WK175 induces apoptotic cell death without any DNA-damaging effect. The apoptotic death signaling pathway initiated by WK175 was examined in detail: mitochondrial membrane potential, cytochrome c release, caspase 3 activation, caspase 3 and poly(ADP-ribose) polymerase cleavage, and the appearance of a sub-G₁ cell cycle population were determined in time course studies in THP-1 (a human monocytic leukemia cell line) cells. We found activation of this cascade after 24 h of treatment with 10 nM WK175. Induction of apoptosis was prevented by bongkrekic acid, Z-Asp-Glu-Val-Asp-fluoromethylketone, and Z-Leu-Glu-His-Asp-fluoromethylketone, inhibitors of the mitochondrial permeability transition and of caspase 3 and 9, respectively, but not by Ac-Tyr-Val-Ala-Asp-CHO, a specific caspase 1 inhibitor, suggesting the involvement of the permeability transition pore, caspase 3, and caspase 9 in the WK175-induced apoptotic cascade. These results imply that decreased NAD⁺ concentration initiates the apoptotic cascade, resulting in the antitumor effect of WK175.

This article has been cited by other articles:

				A. Nahimana, A. Attinger, D. Aubry, P. Greaney, C. Ireson, A. V. Thougaard, J. Tjornelund, K. M. Dawson, M. Dupuis, and M. A. Duchosal The NAD biosynthesis inhibitor APO866 has potent antitumor activity against hematologic malignancies Blood, April 2, 2009; 113(14): 3276 - 3286. [Abstract] [Full Text] [PDF]

				A. Rongvaux, M. Galli, S. Denanglaire, F. Van Gool, P. L. Dreze, C. Szpirer, F. Bureau, F. Andris, and O. Leo Nicotinamide Phosphoribosyl Transferase/Pre-B Cell Colony-Enhancing Factor/Visfatin Is Required for Lymphocyte Development and Cellular Resistance to Genotoxic Stress J. Immunol., October 1, 2008; 181(7): 4685 - 4695. [Abstract] [Full Text] [PDF]

				M. Muruganandham, A. A. Alfieri, C. Matei, Y. Chen, G. Sukenick, I. Schemainda, M. Hasmann, L. B. Saltz, and J. A. Koutcher Metabolic Signatures Associated with a NAD Synthesis Inhibitor-Induced Tumor Apoptosis Identified by 1H-Decoupled-31P Magnetic Resonance Spectroscopy Clin. Cancer Res., May 1, 2005; 11(9): 3503 - 3513. [Abstract] [Full Text] [PDF]

				M. Hasmann and I. Schemainda FK866, a Highly Specific Noncompetitive Inhibitor of Nicotinamide Phosphoribosyltransferase, Represents a Novel Mechanism for Induction of Tumor Cell Apoptosis Cancer Res., November 1, 2003; 63(21): 7436 - 7442. [Abstract] [Full Text] [PDF]